We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+1.19%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$17.7B
AUM Growth
+$1.44B
Cap. Flow
+$1.58B
Cap. Flow %
8.95%
Top 10 Hldgs %
19.92%
Holding
1,403
New
439
Increased
358
Reduced
346
Closed
241

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$403M
2
DIS icon
Walt Disney
DIS
+$157M
3
CELG
Celgene Corp
CELG
+$141M
4
C icon
Citigroup
C
+$137M
5
SBUX icon
Starbucks
SBUX
+$132M

Sector Composition

Rank Sector Weight
1 Technology 24.11%
2 Financials 17.79%
3 Healthcare 17.78%
4 Consumer Staples 7.98%
5 Consumer Discretionary 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LECO icon
801
Lincoln Electric
LECO
$15.4B
$1.08M 0.01%
17,700
+2,600
+17% +$172K
EXAC
802
DELISTED
Exactech Inc
EXAC
$1.08M 0.01%
51,765
-5,690
-10% -$128K
CEVA icon
803
CEVA Inc
CEVA
$1.08B
$1.07M 0.01%
55,173
+22,645
+70% +$463K
CNQ icon
804
Canadian Natural Resources
CNQ
$93.8B
$1.07M 0.01%
+81,294
New +$1.22M
SLGN icon
805
Silgan Holdings
SLGN
$4.41B
$1.06M 0.01%
40,226
-28,894
-42% -$801K
ROL icon
806
Rollins
ROL
$18.2B
$1.04M 0.01%
+82,150
New +$927K
LHX icon
807
L3Harris
LHX
$53.4B
$1.04M 0.01%
13,500
-93,313
-87% -$7.4M
MMSI icon
808
Merit Medical Systems
MMSI
$5.32B
$1.03M 0.01%
+47,898
New +$972K
NPKI
809
NPK International
NPKI
$1.14B
$1.03M 0.01%
+126,983
New +$1.18M
GHDX
810
DELISTED
Genomic Health, Inc.
GHDX
$1.02M 0.01%
+36,812
New +$1.04M
TRIB
811
Trinity Biotech
TRIB
$8.39M
$1.02M 0.01%
377
-99
-21% -$257K
FLWS icon
812
1-800-Flowers.com
FLWS
$258M
$1.02M 0.01%
97,524
+50,000
+105% +$518K
GPRE icon
813
Green Plains
GPRE
$1.03B
$1.02M 0.01%
+37,001
New +$1.14M
SMRT
814
DELISTED
Stein Mart Inc
SMRT
$1.02M 0.01%
97,318
+77,600
+394% +$892K
AUD
815
DELISTED
Audacy, Inc.
AUD
$1.01M 0.01%
88,876
-14,445
-14% -$174K
ANAT
816
DELISTED
American National Group, Inc. Common Stock
ANAT
$1.01M 0.01%
9,895
WMGI
817
DELISTED
Wright Medical Group Inc
WMGI
$1.01M 0.01%
38,500
+25,200
+189% +$666K
IDCC icon
818
InterDigital
IDCC
$8.89B
$1.01M 0.01%
17,762
-36,839
-67% -$2.06M
CINF icon
819
Cincinnati Financial
CINF
$27.1B
$1.01M 0.01%
+20,064
New +$1.03M
CCO icon
820
Clear Channel Outdoor Holdings
CCO
$1.23B
$1M 0.01%
99,201
-39,359
-28% -$429K
LM
821
DELISTED
Legg Mason, Inc.
LM
$1M 0.01%
19,504
+14,900
+324% +$803K
SPWH icon
822
Sportsman's Warehouse
SPWH
$46M
$1M 0.01%
+88,233
New +$883K
FIX icon
823
Comfort Systems
FIX
$59.6B
$1M 0.01%
+43,600
New +$958K
ADC icon
824
Agree Realty
ADC
$9.41B
$1M 0.01%
34,266
+10,600
+45% +$328K
CCK icon
825
Crown Holdings
CCK
$13.1B
$1M 0.01%
18,895
-128,778
-87% -$7.09M

Similar funds

Arrowstreet Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Arrowstreet Capital held 1,403 positions worth $17.7B, up 8.9% from $16.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Arrowstreet Capital deployed $1.58B of net new capital in Q2 2015, opening 439 new positions and adding to 358 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,922,584 shares worth $114M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Union Pacific, an estimated $244M trimmed.

  • Arrowstreet Capital's largest Q2 2015 buy was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
  • Arrowstreet Capital added most to Apple in Q2 2015, an estimated $403M increase.
  • Arrowstreet Capital's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $244M.
  • Arrowstreet Capital fully exited Canadian National Railway in Q2 2015, selling an estimated $146M.
  • Arrowstreet Capital's ten largest holdings make up 20% of its $17.7B portfolio in Q2 2015.
  • Arrowstreet Capital opened 439 new positions and closed 241 in Q2 2015.
  • Arrowstreet Capital's portfolio value rose 8.9% quarter-over-quarter to $17.7B.

Based on Arrowstreet Capital's 13F filing for Q2 2015, filed 13 Aug 2015.